$2.62
0.00%
Nasdaq, Oct 02, 01:15 pm EDT. Market open.
ISIN
US42328V5049
Symbol
HSDT

Helius Medical Technologies Inc Class A Target price 2026 - Analyst rating & recommendation

Helius Medical Technologies Inc Class A Classifications & Recommendation

Buy
88%
Hold
13%

Helius Medical Technologies Inc Class A Price Target

Target Price $3.32
Price $2.62
Potential
Number of Estimates 4
4 Analysts have issued a price target Helius Medical Technologies Inc Class A 2027 . The average Helius Medical Technologies Inc Class A target price is $3.32. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 7 Analysts recommend Helius Medical Technologies Inc Class A to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Helius Medical Technologies Inc Class A stock has an average upside potential 2027 of . Most analysts recommend the Helius Medical Technologies Inc Class A stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 6.02 12.34
1,057.69% 105.02%
Net Margin -679.24% -764.02%
69.91% 12.48%

4 Analysts have issued a sales forecast Helius Medical Technologies Inc Class A 2026 . The average Helius Medical Technologies Inc Class A sales estimate is

$12.3m
unlock
. This is
2.25% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$13.9m 14.83%
unlock
, the lowest is
$10.8m 10.69%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $6.0m 1,057.69%
2026
$12.3m 105.02%
unlock
2027
$12.3m 0.41%
unlock
2028
$17.3m 41.08%
unlock

4 Helius Medical Technologies Inc Class A Analysts have issued a net profit forecast 2026. The average Helius Medical Technologies Inc Class A net profit estimate is

$-94.3m
unlock
. This is
40.04% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-90.6m 42.39%
unlock
, the lowest is
$-97.1m 38.28%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-40.9m 248.30%
2026
$-94.3m 130.62%
unlock
2027
$590k 100.63%
unlock
2028
$-22.3m 3,872.88%
unlock

Net Margin

2025 -679.24% 69.91%
2026
-764.02% 12.48%
unlock
2027
4.77% 100.62%
unlock
2028
-128.35% 2,790.78%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.85 -1.64
99.94% 11.35%
P/E negative
EV/Sales 10.65

4 Analysts have issued a Helius Medical Technologies Inc Class A forecast for earnings per share. The average Helius Medical Technologies Inc Class A EPS is

$-1.64
unlock
. This is
16.75% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-1.69 14.21%
unlock
, the lowest is
$-1.58 19.80%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.85 99.94%
2026
$-1.64 11.35%
unlock
2027
$0.01 100.61%
unlock
2028
$-0.39 4,000.00%
unlock

P/E ratio

Current -1.33 12,565.71%
2026
-1.60 20.31%
unlock
2027
256.86 16,153.75%
unlock
2028
-6.76 102.63%
unlock

Based on analysts' sales estimates for 2026, the Helius Medical Technologies Inc Class A stock is valued at an EV/Sales of

10.65
unlock
and an P/S ratio of
12.83
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.89 65.42%
2026
10.65 2.21%
unlock
2027
10.69 0.42%
unlock
2028
7.58 29.12%
unlock

P/S ratio

Current 13.12 61.48%
2026
12.83 2.21%
unlock
2027
12.89 0.42%
unlock
2028
9.13 29.12%
unlock

Current Helius Medical Technologies Inc Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
B. Riley Securities
Locked
➜
Locked
Locked Sep 22 2026
B. Riley Securities
Locked
➜
Locked
Locked Sep 03 2026
B. Riley Securities
Locked
➜
Locked
Locked Aug 17 2026
Maxim Group
Locked
➜
Locked
Locked Oct 16 2024
Analyst Rating Date
Locked
B. Riley Securities:
Locked
➜
Locked
Sep 22 2026
Locked
B. Riley Securities:
Locked
➜
Locked
Sep 03 2026
Locked
B. Riley Securities:
Locked
➜
Locked
Aug 17 2026
Locked
Maxim Group:
Locked
➜
Locked
Oct 16 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today